Genelux (GNLX) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

GNLX Genelux

Watchlist

2.390
+0.090+3.91%

Close Dec 24 13:00 ET

82.55MMarket Cap-2.98P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Genelux Corporation to Participate in a Fireside Chat With H.C. Wainwright
GeneluxDec 13 00:00 ET
Maxim Group Maintains Genelux(GNLX.US) With Buy Rating, Maintains Target Price $10
Moomoo NewsNov 16 12:31 ET · Ratings
Genelux Corp's Strategic Advances in Cancer Trials Position GNLX as a Promising Investment
TipRanksNov 16 11:45 ET
Disney To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Friday
BenzingaNov 15 07:48 ET
Genelux Is Maintained at Buy by HC Wainwright & Co.
Dow JonesNov 15 07:35 ET · Ratings
Express News | Genelux Corporation : H.c. Wainwright Cuts Target Price to $30 From $32
ReutersNov 15 06:12 ET

Comments

Trytosaveabit

Oct 22 15:03

Update

$Genelux (GNLX.US)$ Reuters· 1 min ago
Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy With Olvi-Vec in Non-Small Cell Lung Cancer

Jaguar8

Oct 22 15:01

NEWS

$Genelux (GNLX.US)$
Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung Cancer

Mcsnacks H Tupack

Sep 17 02:08

Top propsective stocks

$Genelux (GNLX.US)$ 5 analysts have this as a buy. Also close to a gap up but could take a few days to reach that gap but will be worth it.
$Healthy Choice Wellness (HCWC.US)$ 2nd day rally. Im in at 5.15.
$Kairos Pharma (KAPA.US)$ Also. Im in at 2.25.
$Knightscope (KSCP.US)$ Extremely high short interest after RS. Buying in at open with a goal of 7.75.
Plan on being in the green and up 40% at the end of the day.

Jaguar8

Aug 14 15:07

MEWS ER

$Genelux (GNLX.US)$
Genelux Corporation Reports Second Quarter 2024 Financial Results and Provides General Business Updates
Genelux (NASDAQ: GNLX) reported its Q2 2024 financial results and provided business updates. The company completed a $30 million public offering, providing runway through three trial readouts. Genelux anticipates interim results from the Phase 2 trial in recurrent non-small cell lung cancer by mid-2025 and interim data from the Phase 1b trial in recurrent small cell...

frogoracletrading

Jul 11 09:02

$GNLX Support / Resistance Levels

Pushing back into the 90 day POC. Above 2.70 could make a run at the open GAP above.
Larger Image: tradingview.com...
$Genelux (GNLX.US)$

Heat List

Overall

No Data